login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
All US stocks
All Canadian stocks
All European stocks
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
MEDMIRA INC (MIR.CA) Stock News
TSX-V:MIR - TSX Venture Exchange -
CA58501R1029
-
Common Stock
- Currency: CAD
0.07
0 (-6.67%)
Summary
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
MIR.CA Latest News, Press Relases and Analysis
All
Press Releases
17 days ago - By: ACCESS Newswire
MedMira Announces Launch of Clinical Trial for Its Multiplo(R) TP/HIV Self-Test in Canada
24 days ago - By: ACCESS Newswire
MedMira Reports Second Quarter Results FY2025
3 months ago - By: ACCESS Newswire
MedMira Inc. and Lovell Announce Partnership to Increase Access to Reveal(R) G4 HIV-1/2 rapid test for VA, Department of Defense
4 months ago - By: ACCESS Newswire
MedMira Reports Second Quarter Results FY2025
5 months ago - By: ACCESS Newswire
MedMira Announces Partnership with MediGroup Physician Services in the United States
5 months ago - By: ACCESS Newswire
MedMira Announces Exclusive Distribution Agreement with Trimedic Inc. for Canada
6 months ago - By: ACCESS Newswire
MedMira Receives Investigational Testing Authorizations for Multiplo(R) TP/HIV Self-Test and Non-Professional Use Applications
2 years ago - By: Maternova, Inc.
- Mentions:
TSX
Maternova and MedMira Enter Distribution Agreement to Market Rapid Diagnostics for HIV, Syphilis and Hepatitis
3 years ago - By: MedMira Inc.
MedMira Strengthens and Expands Board
3 years ago - By: MedMira Inc.
MedMira Reports Third Quarter Results FY2022
3 years ago - By: MedMira Inc.
MedMira Receives Patent for its Unique Quantitative Diagnostic System
3 years ago - By: MedMira Inc.
MedMira provides an update on the new In Vitro Diagnostic Medical Devices Regulation (IVDR) in the European Market
Please enable JavaScript to continue using this application.